MedSim acquires Eagle Simulation
Medical imaging simulation firm MedSim of Kfar Sava, Israel, has acquired Eagle Simulation of Binghamton, NY. The deal improves MedSim’s market position and expands its product line to include Eagle’s PatSim, a computer-controlled mannequin
Medical imaging simulation firm MedSim of Kfar Sava, Israel, has acquired Eagle Simulation of Binghamton, NY. The deal improves MedSims market position and expands its product line to include Eagles PatSim, a computer-controlled mannequin with cardiac, pulmonary, metabolic, and physiologic simulation functions. With the acquisition, MedSims worldwide installations will grow to more than 120 systems, and its annual consolidated sales will increase from $3.5 million to $8 million. Eagle will add 25 employees to MedSims roster, according to the company.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
